BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2579616)

  • 1. Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series.
    Boronow J; Pickar D; Ninan PT; Roy A; Hommer D; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1985 Mar; 42(3):266-71. PubMed ID: 2579616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical atrophy in schizophrenia and mania: a comparative CT study.
    Nasrallah HA; McCalley-Whitters M; Jacoby CG
    J Clin Psychiatry; 1982 Nov; 43(11):439-41. PubMed ID: 7174617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid.
    Doran AR; Boronow J; Weinberger DR; Wolkowitz OM; Breier A; Pickar D
    Neuropsychopharmacology; 1987 Dec; 1(1):25-32. PubMed ID: 3509912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers.
    Nybäck H; Berggren BM; Hindmarsh T; Sedvall G; Wiesel FA
    Psychiatry Res; 1983 Aug; 9(4):301-8. PubMed ID: 6196802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
    Houston JP; Maas JW; Bowden CL; Contreras SA; McIntyre KL; Javors MA
    Psychiatry Res; 1986 Nov; 19(3):207-14. PubMed ID: 3797547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenic symptoms and deterioration. Relation to computed tomographic findings.
    Pandurangi AK; Bilder RM; Rieder RO; Mukherjee S; Hamer RM
    J Nerv Ment Dis; 1988 Apr; 176(4):200-6. PubMed ID: 3351498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third ventricular enlargement on CT scans in schizophrenia: association with cerebellar atrophy.
    Nasrallah HA; Jacoby CG; Chapman S; McCalley-Whitters M
    Biol Psychiatry; 1985 Apr; 20(4):443-50. PubMed ID: 3978176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized tomography of the brain in schizophrenic patients. A controlled study.
    Tanaka Y; Hazama H; Kawahara R; Kobayashi K
    Acta Psychiatr Scand; 1981 Mar; 63(3):191-7. PubMed ID: 6972151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.
    van Kammen DP; Peters J; Yao J; Neylan T; Beuger M; Pontius E; O'Connor DT
    Schizophr Res; 1991 Dec; 6(1):31-9. PubMed ID: 1723893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
    Losonczy MF; Song IS; Mohs RC; Mathé AA; Davidson M; Davis BM; Davis KL
    Am J Psychiatry; 1986 Sep; 143(9):1113-8. PubMed ID: 2428259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect.
    Shelton RC; Karson CN; Doran AR; Pickar D; Bigelow LB; Weinberger DR
    Am J Psychiatry; 1988 Feb; 145(2):154-63. PubMed ID: 3277448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide and aggression in schizophrenia. Neurobiologic correlates.
    Pickar D; Roy A; Breier A; Doran A; Wolkowitz O; Colison J; Agren H
    Ann N Y Acad Sci; 1986; 487():189-96. PubMed ID: 2436533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical and central atrophy in chronic schizophrenia. A controlled study.
    Okasha A; Madkour O
    Acta Psychiatr Scand; 1982 Jan; 65(1):29-34. PubMed ID: 7187173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography scans and negative symptoms in schizophrenia: chronic schizophrenics with negative symptoms and nonenlarged lateral ventricles.
    Serban G; George A; Siegel S; DeLeon M; Gaffney M
    Acta Psychiatr Scand; 1990 May; 81(5):441-7. PubMed ID: 2356766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D; Breier A; Hsiao JK; Doran AR; Wolkowitz OM; Pato CN; Konicki PE; Potter WZ
    Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M; Ninan PT; Scheinin M; Waters RN; Chang WH; Bartko J; van Kammen DP
    Arch Gen Psychiatry; 1983 Dec; 40(12):1290-4. PubMed ID: 6197036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT scan and MRI findings in a child with schizophrenia.
    Woody RC; Bolyard K; Eisenhauer G; Altschuler L
    J Child Neurol; 1987 Apr; 2(2):105-10. PubMed ID: 3598138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ventricular system in chronic schizophrenic patients. A controlled computed tomography study.
    Pandurangi AK; Dewan MJ; Lee SH; Ramachandran T; Levy BF; Boucher M; Yozawitz A; Major L
    Br J Psychiatry; 1984 Feb; 144():172-6. PubMed ID: 6608390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
    Lewine RR; Risch SC; Risby E; Stipetic M; Jewart RD; Eccard M; Caudle J; Pollard W
    Am J Psychiatry; 1991 Sep; 148(9):1189-94. PubMed ID: 1715677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.